Materials

Bio-Gene Technology Ltd (BGT)

Bio-Gene Technology Ltd (ASX: BGT) is an Australian small-cap technology company operating in the Materials sector. Specifically, it develops innovative, sustainable, and natural solutions for pest and weed control in agriculture, leveraging its proprietary technologies to produce environmentally friendly herbicides and pesticides. Primarily, it operates within Australia but aims for global market expansion.

Market Cap

A$11M

Shares on Issue

N/A

Company WebsiteAI coverage updated hourlyData from ASX filings

Price Chart

Loading chart…

AI Analysis

As of its last update, BGT is in a developmental stage with a market cap of A$9M, indicating its speculative and high-risk nature typical of micro-cap stocks. Recent performance may show modest revenue growth from early product sales or licensing agreements, with key metrics focusing on R&D progress and regulatory approvals.

Growth outlook hinges on successful product launches, expansion into key international markets, and strategic partnerships. Upcoming catalysts could include pivotal trial data for its natural herbicides, regulatory approvals in the US or EU, and announcements of commercial-scale production partnerships.

Bull Case

  • Successful global market entry of its flagship natural pesticide product could capture a significant share of the growing organic farming inputs market.
  • Strategic partnership with a major agrochemical company could accelerate development and distribution.
  • Favorable regulatory shifts towards stricter chemical pesticide regulations could exponentially increase demand for BGT's products.

Bear Case

  • Failure to achieve regulatory approval in major markets (e.g., US, EU) could severely hinder growth plans.
  • Intense competition from established agrochemical companies adapting to sustainable trends.
  • Higher-than-anticipated production costs could erode profit margins, challenging long-term viability.

Recent Announcements

Regulatory Development of Flavocide

🚨 Price Sensitive
2 Mar 2026Progress Report

Regulatory Development of Flavocide

Appendix 4D and Half-Year Accounts 31 December 2025

🚨 Price Sensitive
23 Feb 2026Price Sensitive

Appendix 4D and Half-Year Accounts 31 December 2025

Update on Qcide Production

9 Mar 2026Progress Report

FAQs

What does BGT do?

Bio-Gene Technology develops and commercializes natural, sustainable pest and weed control solutions for agriculture.

Is BGT a good investment?

BGT offers high growth potential due to its innovative products, but as a micro-cap with speculative investments, it carries high risk, especially for income-seeking investors given its pre-dividend stage.

What drives BGT's share price?

Key drivers include regulatory approval news, successful trial data, partnership announcements, and broader market trends in sustainable agriculture and materials.